Comet Therapeutics picks up $28.5 mln Series A
Comet Therapeutics, a biotech firm, has raised $28.5 million in Series A funding. Canaan and Sofinnova Partners led the round.
20 June 2019•1 min read
Comet Therapeutics, a biotech firm, has raised $28.5 million in Series A funding. Canaan and Sofinnova Partners led the round.
